Table 1.

Background features of both groups

	Group A (infliximab)	Group B(MTX)	p value
n	34	42
age (mean±SD)	55.1±14.3	58.5±14.2	n.s*
sex (female/male)	29/5	37/5	n.s**
Disease duration (year) (mean±SD)	5.42±5.62	4.46±8.89	n.s*
Dosage of steroid (mg) (mean±SD)	5.7±3.0	3.2±3.3	>0.001*
DAS28-ESR4 (mean±SD)	5.53±1.31	5.22±0.93	n.s*
mHAQ (mean±SD)	0.70±0.66	0.60±0.56	n.s*
SDS (mean±SD)	44.8±10.9	44.0±9.9	n.s*

DAS: disease activity score; mHAQ: modified Health Assessment Questionnaire; SDS: self-rating depression scale

^*analysis by Mann-Whitney U-test

^**analysis by Fisher’s exact probability test